PortfolioRupert Handgretinger
Person data
Academic title:
Prof. Dr.
Name:
Rupert Handgretinger
Organizational unit:
Faculty of Medicine
University of Tübingen
Contact data
Curriculum vitae
Scientific Career History
1979-1986 | Medical School, Universities of Essen and Tübingen, Germany |
21.05.1986 | Approbation (Certified physician), |
issuing authority: Regierungspräsidium Stuttgart | |
1986-1989 | Research Fellow of the "Mildred Scheel Cancer Aid", University of Tübingen |
1989 | University of Tübingen, MD Thesis: |
Untersuchungen zum Einsatz von Interleukin 2 in der Behandlung des metasierenden Neuroblastoms | |
1989-1994 | Pediatric Residency, Children`s University Hospital, Tübingen |
1994 | German Board of Pediatrics |
1996 | University of Tübingen, Habilitation ( Postdoctoral thesis in Pediatrics): |
Untersuchungen zur Immuntherapie mit monoklonalen Antikörpern beim metastasierenden Neuroblastom | |
1989-2000 | Director of the Stem Cell Processing Laboratory at the Children`s University Hospital, Tübingen |
1994-2000 | Head Physician, General Pediatrics and Division of Hematology/Oncology, University Hospital Tübingen |
2000-2005 | Full Faculty Member and Director of the Division of Stem Cell Transplantation, Department of Hematology/Oncology, St. Jude Children`s Research Hospital, Memphis, TN, USA |
2000-2005 | Professor, Department of Pediatrics, The University of Tennessee Health Science Center, Memphis, TN, USA |
2005 to present | Professor, Department of Surgery, The University of Tennessee Health Science Center, Memphis, TN, USA |
2005 to present | Medical Director, Department of General Pediatrics and Hematology/Oncology, Children`s University Hospital Tübingen, Germany |
2011 to present | Chairman, Children`s University Hospital Tübingen, Germany |
Patents
30/10/2014
09/12/2020
Gregor Blank, Rupert Handgretinger, Karin Schilbach-Stückle
Gina Lacorcia, Andreas Menrad, Daniel Snell
Projects
2021 - 2022
Markus Mezger
Stefan-Morsch-Stiftung
2020 - 2023
Martin Ebinger
Madeleine Schickedanz-KinderKrebs-Stiftung
2020
Marcus Weitz
Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen (NMI)
2020
Ute Graepler-Mainka
Boehringer Ingelheim Pharma GmbH & Co. KG
2019 - 2022
Patrick Schlegel
Deutsche Forschungsgemeinschaft e.V. (DFG)
2019 - 2022
Christian Seitz
Deutsche Forschungsgemeinschaft e.V. (DFG)
2019 - 2021
Patrick Schlegel
Dres. Carl Maximilian und Carl Manfred Bayer-Stiftung
2019 - 2025
Hans-Georg Rammensee, Lars Zender, Bernd Pichler
Deutsche Forschungsgemeinschaft e.V. (DFG)
2019 - 2021
Ines Beatrice Brecht
2018 - 2020
Rupert Handgretinger
Deutsche José Carreras Leukämie-Stiftung e.V.
2018 - 2019
Martin Ebinger, Rupert Handgretinger
Deutsches Krebsforschungszentrum (DKFZ)
2018 - 2020
Ines Beatrice Brecht
Europäische Kommission
2017 - 2020
Peter Lang, Rupert Handgretinger
2017 - 2020
Gerhard Binder, Roland Schweizer, Julian Ziegler
2017 - 2020
Patrick Schlegel, Christian Seitz
Hilfe für kranke Kinder e.V.
2016 - 2021
Rupert Handgretinger
2015 - 2024
Martin Ebinger
Universitätsklinikum Hamburg Eppendorf (UKE)
2015 - 2024
Martin Ebinger
Universitätsklinikum Hamburg Eppendorf (UKE)
2014 - 2020
Peter Lang
APEIRON Biologics AG
2000 - 2019
Martin Ebinger
Universitätsklinikum Hamburg Eppendorf (UKE)